Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,404
Closed -$2.42M 534
2023
Q4
$2.42M Buy
+8,404
New +$2.29M 0.15% 184
2022
Q4
Sell
-78
Closed -$18K 130
2022
Q3
$18K Sell
78
-31,951
-100% -$7.74M ﹤0.01% 1631
2022
Q2
$7.79M Buy
32,029
+21,701
+210% +$5.32M 0.29% 69
2022
Q1
$2.5M Buy
+10,328
New +$2.37M 0.09% 270
2021
Q4
Sell
-1,159
Closed -$245K 1858
2021
Q3
$246K Buy
+1,159
New +$267K 0.01% 1123
2021
Q1
Sell
-8,246
Closed -$1.97M 1775
2020
Q4
$1.9M Buy
+8,246
New +$1.9M 0.09% 290
2020
Q2
Sell
-329
Closed -$67K 1128
2020
Q1
$67K Buy
329
+84
+34% +$18.3K 0.03% 281
2019
Q4
$59K Buy
+245
New +$54K 0.01% 645
2019
Q3
Sell
-230
Closed -$42K 979
2019
Q2
$42K Sell
230
-1,598
-87% -$286K 0.01% 658
2019
Q1
$347K Buy
+1,828
New +$349K 0.14% 76
2018
Q3
Sell
-262
Closed -$48K 870
2018
Q2
$48K Buy
262
+128
+96% +$22.6K 0.02% 435
2018
Q1
$23K Buy
+134
New +$24.6K 0.01% 596
2017
Q2
Sell
-243
Closed -$40K 801
2017
Q1
$40K Buy
243
+72
+42% +$12K 0.05% 279
2016
Q4
$25K Buy
171
+71
+71% +$10.7K 0.02% 507
2016
Q3
$17K Sell
100
-300
-75% -$50.7K 0.01% 605
2016
Q2
$61K Buy
+400
New +$62.2K 0.07% 231
2015
Q2
Sell
-3,191
Closed -$510K 175
2015
Q1
$510K Buy
3,191
+244
+8% +$38.4K 0.45% 22
2014
Q4
$469K Buy
+2,947
New +$459K 0.46% 36

Other funds holding AMGN

Point72 Hong Kong's AMGN Position: Q1 2024 in Review

Point72 Hong Kong sold out of Amgen (AMGN) in Q1 2024, closing a stake of 8,404 shares — an estimated $2.42M sold.

Point72 Hong Kong first reported a position in AMGN in Q4 2014 and held it in 18 quarters. The position peaked at $7.79M in Q2 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Point72 Hong Kong reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 8,404 Amgen shares in Q1 2024, an estimated $2.42M.
  • Point72 Hong Kong first reported a position in Amgen in Q4 2014 and held it in 18 quarters.
  • Point72 Hong Kong's Amgen position peaked at $7.79M in Q2 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.